← Back to headlines
Pfizer Q1 2026 Earnings Beat Estimates Driven by Newer Drugs
Pfizer reported its first-quarter 2026 earnings, which surpassed analyst estimates. The pharmaceutical giant attributed the strong performance to the growth of its newer drug portfolio.
5 May, 12:45 — 5 May, 12:45
Sources
Showing 1 of 1 sources
